| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.92B | 26.47B | 22.81B | 21.32B | 20.10B | 19.10B |
| Gross Profit | 4.52B | 4.78B | 4.32B | 3.89B | 3.59B | 3.35B |
| EBITDA | 1.91B | 1.91B | 1.94B | 1.77B | 1.35B | 1.61B |
| Net Income | 1.25B | 1.36B | 1.22B | 1.16B | 1.11B | 1.00B |
Balance Sheet | ||||||
| Total Assets | 39.27B | 40.84B | 37.96B | 32.54B | 31.82B | 31.95B |
| Cash, Cash Equivalents and Short-Term Investments | 2.41B | 1.64B | 2.00B | 443.00M | 736.00M | 1.04B |
| Total Debt | 9.40B | 9.38B | 8.40B | 5.30B | 5.41B | 6.14B |
| Total Liabilities | 21.85B | 22.04B | 20.49B | 16.09B | 16.57B | 17.25B |
| Stockholders Equity | 16.82B | 18.13B | 16.82B | 15.84B | 14.72B | 14.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -80.00M | -115.00M | 167.00M | 1.13B | 894.00M |
| Operating Cash Flow | 0.00 | 131.00M | 24.00M | 335.00M | 1.25B | 1.08B |
| Investing Cash Flow | 0.00 | -953.00M | -829.00M | -171.00M | -115.00M | -191.00M |
| Financing Cash Flow | 0.00 | 466.00M | 2.36B | -456.00M | -1.44B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥6.02T | 11.49 | 10.32% | 3.30% | 15.72% | 30.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥12.90B | 9.70 | ― | 3.57% | 16.06% | 11.67% | |
62 Neutral | ¥1.92T | 12.40 | 8.92% | 3.20% | 5.96% | 19.95% | |
61 Neutral | ¥380.99B | 8.17 | ― | 3.65% | 32.52% | 9.94% | |
56 Neutral | ¥155.95B | 10.53 | ― | 4.42% | 1.18% | -28.29% | |
52 Neutral | ¥190.50B | 13.99 | ― | 3.30% | 8.46% | -18.12% |